Axalta Coating Systems Ltd.

DB:9AX Stock Report

Market Cap: €5.8b

Axalta Coating Systems Valuation

Is 9AX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of 9AX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: 9AX (€27) is trading below our estimate of future cash flow value (€64.91)

Significantly Below Future Cash Flow Value: 9AX is trading below future cash flow value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 9AX?

Key metric: As 9AX is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 9AX. This is calculated by dividing 9AX's market cap by their current earnings.
What is 9AX's PE Ratio?
PE Ratio17.9x
EarningsUS$378.00m
Market CapUS$6.76b

Price to Earnings Ratio vs Peers

How does 9AX's PE Ratio compare to its peers?

The above table shows the PE ratio for 9AX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average56x
EVK Evonik Industries
10.2x-4.26%€6.5b
SY1 Symrise
19.5x7.96%€9.9b
WCH Wacker Chemie
169x48.46%€3.7b
ACT AlzChem Group
25.4x18.59%€1.6b
9AX Axalta Coating Systems
17.9x12.68%€6.8b

Price-To-Earnings vs Peers: 9AX is good value based on its Price-To-Earnings Ratio (17.9x) compared to the peer average (56x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does 9AX's PE Ratio compare vs other companies in the European Chemicals Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
9AX 17.9xIndustry Avg. 17.7xNo. of Companies13PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 9AX is good value based on its Price-To-Earnings Ratio (17.9x) compared to the European Chemicals industry average (19x).

Price to Earnings Ratio vs Fair Ratio

What is 9AX's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

9AX PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio17.9x
Fair PE Ratio22.7x

Price-To-Earnings vs Fair Ratio: 9AX is good value based on its Price-To-Earnings Ratio (17.9x) compared to the estimated Fair Price-To-Earnings Ratio (22.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 9AX forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€27.00
€32.32
+19.69%
7.98%€37.91€27.80n/a14
Feb ’27€28.20
€30.90
+9.58%
11.25%€37.88€25.25n/a14
Jan ’27€27.60
€31.63
+14.58%
11.17%€36.69€25.60n/a15
Dec ’26€25.60
€31.96
+24.83%
11.58%€37.34€26.05n/a15
Nov ’26€24.60
€31.52
+28.13%
11.42%€37.30€25.16n/a18
Oct ’26€23.80
€31.85
+33.81%
14.10%€40.03€25.55n/a18
Sep ’26€26.60
€32.27
+21.30%
13.94%€40.50€25.85n/a18
Aug ’26€24.00
€32.43
+35.14%
13.53%€40.59€25.91n/a18
Jul ’26€25.80
€33.66
+30.48%
11.58%€43.26€27.14n/a19
Jun ’26€27.00
€35.30
+30.75%
11.04%€44.92€28.19n/a20
May ’26€28.60
€36.17
+26.48%
10.92%€44.85€28.14n/a20
Apr ’26€30.80
€40.41
+31.20%
8.51%€47.24€32.06n/a20
Mar ’26€34.60
€42.10
+21.68%
8.29%€48.65€33.02€28.2020
Feb ’26€34.60
€41.20
+19.08%
9.22%€48.89€33.18€28.2020
Jan ’26€32.60
€42.38
+30.01%
7.38%€49.21€37.63€27.6019
Dec ’25€37.60
€41.60
+10.64%
6.51%€47.35€36.93€25.6020
Nov ’25€34.60
€40.19
+16.17%
6.39%€46.14€35.99€24.6019
Oct ’25€32.00
€37.92
+18.51%
6.75%€41.07€31.94€23.8019
Sep ’25€32.60
€37.92
+16.33%
6.75%€41.07€31.94€26.6019
Aug ’25€33.60
€37.44
+11.42%
6.92%€41.70€32.43€24.0019
Jul ’25€31.20
€37.25
+19.40%
6.87%€41.91€30.73€25.8018
Jun ’25€32.60
€37.09
+13.77%
6.89%€41.67€30.55€27.0018
May ’25€29.40
€35.10
+19.40%
9.68%€42.09€28.06€28.6019
Apr ’25€31.40
€33.59
+6.99%
8.53%€38.66€27.61€30.8018
Mar ’25€29.80
€34.08
+14.37%
8.53%€39.22€28.01€34.6018
€32.69
Fair Value
17.4% undervalued intrinsic discount
14
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/04 02:28
End of Day Share Price 2026/03/04 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Axalta Coating Systems Ltd. is covered by 25 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ghansham PanjabiBaird
Michael LeitheadBarclays
Patrick Duffy FischerBarclays